Stay updated on GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA 403 Forbidden error page is now displayed, replacing the prior study record content. The page also adds a Home link and revision note while removing extensive study details and related terms.SummaryDifference18%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedNo textual changes were detected on the page; the study details and related information remain as published. The overall presentation and structure appear unchanged.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6 on the page, indicating a minor template/system update that does not alter the study data.SummaryDifference0.2%

- Check36 days agoChange DetectedAdds a funding note '2017 ( U.S. NIH Grant/Contract )' to the study record, providing context about the study's funding. This contextualizes the source of support for the trial.SummaryDifference0.2%

- Check50 days agoChange DetectedRevision: v3.6.5 was added, replacing the previous v3.6.4. This change represents an update to the page's metadata rather than substantive alterations to the study details or participant information.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a new site revision.SummaryDifference0.1%

Stay in the know with updates to GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.